Submit Deal
All Dealmakers
Similar Dealmakers
Managing Partner at RA CAPITAL MANAGEMENT
Investor
Share Profile
Deal Bio
Market Context
Back to top
All rights reserved. Copyright © 2025 Datasite
Expertise (37)
Key Relationships
Sort
Target: FREENOME
Bidder: T. ROWE PRICE GROUP INC
17 Service Providers
30 Dealmakers
£ 126 M
Value
Target: LEGEND BIOTECH CORPORATION
Bidder: LILLY ASIA VENTURES
8 Service Providers
13 Dealmakers
£ 121 M
Target: EVEREST MEDICINES LTD
Bidder: OCTAGON INVESTMENTS
11 Service Providers
18 Dealmakers
£ 245 M
Target: NOVAVAX
Bidder: RA CAPITAL MANAGEMENT
5 Service Providers
17 Dealmakers
£ 159 M
Target: CEREVEL THERAPEUTICS
Bidder: ECOR1 CAPITAL
27 Service Providers
66 Dealmakers
£ 1.00 B
Target: KINNATE BIOPHARMA
Bidder: NEXTECH INVEST
9 Service Providers
9 Dealmakers
£ 74 M
Target: LIANBIO
Bidder: LOGOS CAPITAL
18 Service Providers
£ 239 M
Target: IO BIOTECH
Bidder: VIVO CAPITAL LLC
16 Service Providers
16 Dealmakers
£ 113 M
Target: TSCAN THERAPEUTICS
Bidder: 6 DIMENSIONS CAPITAL
11 Dealmakers
£ 73 M
Target: NAUTILUS BIOTECHNOLOGY
Bidder: ARYA SCIENCES ACQUISITION CORP III
21 Service Providers
44 Dealmakers
£ 654 M
Target: ARTIVA BIOTHERAPEUTICS
Bidder: ACUTA CAPITAL
n/a
Target: CENTURY THERAPEUTICS
Bidder: FIDELITY MANAGEMENT & RESEARCH COMPANY
14 Service Providers
24 Dealmakers
£ 115 M
Target: ICOSAVAX INC
Bidder: SANOFI VENTURES
13 Service Providers
19 Dealmakers
£ 71 M
Target: GH RESEARCH
Bidder: DEERFIELD MANAGEMENT COMPANY
10 Service Providers
20 Dealmakers
£ 91 M
Target: AFFINIA THERAPEUTICS
Bidder: CASDIN CAPITAL
15 Dealmakers
£ 80 M
Target: NIKANG THERAPEUTICS
Bidder: SURVEYOR CAPITAL
23 Service Providers
29 Dealmakers
£ 141 M
Target: SYNTHEKINE
Bidder: JANUS HENDERSON INVESTORS
£ 75 M
Target: ELEMENT BIOSCIENCES
Bidder: COUNTERPOINT GLOBAL - MORGAN STANLEY
12 Dealmakers
£ 198 M
Target: PARDES BIOSCIENCES
37 Dealmakers
£ 199 M
Target: ANTIOS THERAPEUTICS
Bidder: AMZAK CAPITAL MANAGEMENT
19 Service Providers
22 Dealmakers
£ 69 M
Target: EXO
Bidder: PURA VIDA INVESTMENTS
6 Service Providers
6 Dealmakers
£ 158 M
Target: T-KNIFE
Bidder: CAAS CAPITAL MANAGEMENT
12 Service Providers
£ 79 M
Target: GENTIBIO
Bidder: MATRIX CAPITAL MANAGEMENT
7 Service Providers
7 Dealmakers
Target: POINT BIOPHARMA
Bidder: RESEARCH ALLIANCE CORP I
£ 419 M
Target: METAGENOMI
Bidder: MODERNA
£ 129 M
Target: SOMATUS
Bidder: WELLINGTON MANAGEMENT
15 Service Providers
14 Dealmakers
£ 238 M
Target: BE BIO
Bidder: ATLAS VENTURE LP
10 Dealmakers
£ 99 M
Target: MBX BIOSCIENCES
8 Dealmakers
£ 97 M
Target: CG ONCOLOGY
Bidder: ALLY BRIDGE GROUP
£ 101 M
Target: VAXESS
Bidder: THE ENGINE
5 Dealmakers
£ 23 M
Target: LENZ THERAPEUTICS
Bidder: POINT72 VENTURES
Target: CARMOT THERAPEUTICS
Bidder: DEEP TRACK CAPITAL
£ 120 M
Target: ABCURO
Bidder: REDMILE GROUP
Target: GAMETO
Bidder: TWO SIGMA VENTURES
£ 25 M
Target: MEDICENNA THERAPEUTICS
3 Service Providers
3 Dealmakers
£ 11 M
Target: CONCERT PHARMACEUTICALS
Bidder: BVF PARTNERS
£ 47 M
Target: ELECTRA THERAPEUTICS INC
Bidder: EQT LIFE SCIENCES
£ 136 M
